Matthew L.

Matthew L. is a Senior Scientist I at AbbVie, specializing in biologics drug product development and formulation. They possess extensive experience in developing liquid and lyophilized formulations for complex biologics, including mAbs and ADCs, and have supported Phase I/II clinical trials. Matthew earned a PhD in Molecular Pharmaceutics and Drug Delivery from the University of Texas at Austin and a BS in Bioengineering from the University of Maryland, College Park. Their previous positions include roles at the National Institute of Allergy and Infectious Diseases and FDA, where they contributed to purification processes and conducted significant research.